Page last updated: 01 November 2016
Child programs
AgeVaccine
Birth
  • Hepatitis B (hepB)a
2 months
  • Hepatitis B, diphtheria, tetanus, acellular pertussis (whooping cough), Haemophilus influenzae type b, inactivated poliomyelitis (polio) (hepB-DTPa-Hib-IPV)
  • Pneumococcal conjugate (13vPCV)
  • Rotavirus
4 months
  • Hepatitis B, diphtheria, tetanus, acellular pertussis (whooping cough), Haemophilus influenzae type b, inactivated poliomyelitis (polio) (hepB-DTPa-Hib-IPV)
  • Pneumococcal conjugate (13vPCV)
  • Rotavirus
6 months
  • Hepatitis B, diphtheria, tetanus, acellular pertussis (whooping cough), Haemophilus influenzae type b, inactivated poliomyelitis (polio) (hepB-DTPa-Hib-IPV)
  • Pneumococcal conjugate (13vPCV)
  • Rotavirus b
12 months
  • Haemophilus influenzaetype b and meningococcal C (Hib-MenC)
  • Measles, mumps and rubella (MMR)
18 months
  • Diphtheria, tetanus, acellular pertussis (whooping cough)
  • Measles, mumps, rubella and varicella (chickenpox) (MMRV)
4 years
  • Diphtheria, tetanus, acellular pertussis (whooping cough) and inactivated poliomyelitis (polio) (DTPa-IPV)
  • Measles, mumps and rubella (MMR) (to be given only if MMRV vaccine was not given at 18 months)
School programs
AgeVaccine
10–15 years (contact your State or Territory Health Department for details)
  • Varicella (chickenpox) c
  • Human papillomavirus (HPV) d
  • Diphtheria, tetanus and acellular pertussis (whooping cough) (dTpa)
At-risk groupsAboriginal and Torres Strait Islanders
AgeVaccine
12–18 months (In high risk areas) e
  • Pneumococcal conjugate (13vPCV)
12–24 months (In high risk areas) f
  • Hepatitis A
6 months to less than 5 years
  • Influenza (flu)
15 years and over
  • Influenza (flu)
  • Pneumococcal polysaccharide (23vPPV) (medically at risk)
50 years and over
  • Pneumococcal polysaccharide (23vPPV)
Other at-risk groups
AgeVaccine
6 months and over (people with medical conditions placing them at risk of serious complications of influenza)
  • Influenza (flu)
12 months (medically at risk) e
  • Pneumococcal conjugate (13vPCV)
4 years (medically at risk)e
  • Pneumococcal polysaccharide (23vPPV)
Pregnant women (at any stage of pregnancy)
  • Influenza (flu)
65 years and over
  • Influenza (flu)
  • Pneumococcal polysaccharide (23vPPV)
70 years (a free single catch-up dose is available for adults aged 71-79 years until 31 October 2021)
  • Herpes Zoster (Shingles)

Footnotes to the National Immunisation Program (NIP) Schedule

  1. Hepatitis B: vaccine should be given to all infants as soon as practicable after birth. The greatest benefit is if given within 24 hours, and must be given within 7 days
  2. Rotavirus vaccine: third dose of vaccine is dependent on vaccine brand used. Contact your State or Territory Health Department for details.
  3. Varicella vaccine: contact your State or Territory Health Department for details on the school grade eligible for vaccination.
  4. HPV vaccine: is for all adolescents aged between 12 and 13 years. Contact your State or Territory Health Department for details on the school grade eligible for vaccination.
  5. Pneumococcal vaccine:
    1. Medically at risk children require a fourth dose of 13vPCV at 12 months of age and a booster dose of 23vPPV at 4 years of age.
    2. Aboriginal and Torres Strait Islander children require a fourth dose of pneumococcal vaccine (13vPCV) at 12-18 months of age for children living in high risk areas (Queensland, Northern Territory, Western Australia and South Australia). Contact your State or Territory Health Department for details.
  6. Hepatitis A vaccine: two doses of Hepatitis A vaccine for Aboriginal and Torres Strait Islander children living in high risk areas (Queensland, Northern Territory, Western Australia and South Australia). Contact your State or Territory Health Department for details.

In this section